Evotec's Partner Zhejiang Jingxin Pharmaceutical Secures Approval From Chinese Medical Authority For Evotec's Insomnia Drug, EVT201
The FDA Clears C4 Therapeutics' Investigational New Drug Application For CFT8919 For Non-small Cell Lung Cancer; C4T Expects To Initiate Trials Outside Greater China After Betta Pharmaceuticals Concludes Phase 1 Dose Escalation Study In Greater China
CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China
BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded
Press Release: Merus Announces Regulatory Update on Zenocutuzumab, Financial Results for the Third Quarter and Provides Business Update
Shanghai Haohai Biological Technology's Q3 Profit Drops 6.6% as R&D Expenses Rise